SHANK3 and Aicardi-Goutieres syndrome: This has been previously observed in rare observational cohorts of individuals with rare genetic disorders that predispose toward immunotherapy-responsive neuroinflammation such as SHANK3 and Aicardi-Goutières syndrome [14, 38].